CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Heart failure - chronic - Management
How should I manage someone with asthma or COPD as a comorbidity in heart failure?
- Beta-blockers are contraindicated in people with a history of asthma or bronchospasm.
- Beta-blockers can be used in people with stable chronic obstructive pulmonary disease (without reversibility).
- Treatment should be started at a low dose and slowly titrated up.
- If symptoms worsen, a reduction in dose, or withdrawal, may be necessary.
- Bisoprolol or nebivolol may be preferred to carvedilol, as these are more cardioselective.
© NHS Institute for Innovation and Improvement